Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Akrinol
2. 7527-91-5
3. Sch 7056
4. 1,3-benzenediol, 4-hexyl-, Compd. With 9-acridinamine (1:1)
5. Nsc-758691
6. 4-hexylresorcinol Compound With 9-aminoacridine (1:1)
7. 2u918o4bev
8. Acrosorcin; Akrinol; Sch 7056
9. Sch-7056
10. Acrisorcina
11. Acrisorcinum
12. Acrisorcinum [inn-latin]
13. Acrisorcina [inn-spanish]
14. Einecs 231-389-7
15. Unii-2u918o4bev
16. Acrisorcin [usan:usp:inn]
17. Bis(9-aminoacridinium)salz Des Hexylresorcine
18. Bis(9-aminoacridinium 4-hexyl-1,3-resorcindiolat
19. Akrinol (tn)
20. 9-aminoacridine Compd. With 4-hexylresorcinol (1:1)
21. Spectrum_000107
22. Acrisorcin [mi]
23. Specplus_000886
24. Acrisorcin [inn]
25. Acrisorcin (usan/inn)
26. Spectrum2_001107
27. Spectrum3_001213
28. Spectrum4_000625
29. Spectrum5_001392
30. Acrisorcin [usan]
31. Acrisorcin [mart.]
32. Bspbio_002626
33. Kbiogr_001210
34. Kbioss_000547
35. Divk1c_006982
36. Schembl148836
37. Spectrum1504218
38. Spbio_001214
39. Acrisorcin [orange Book]
40. Chembl1201038
41. Kbio1_001926
42. Kbio2_000547
43. Kbio2_003115
44. Kbio2_005683
45. Kbio3_002126
46. Dtxsid10226234
47. Hms1922h03
48. Hms2093c18
49. Pharmakon1600-01504218
50. Ccg-40100
51. Nsc758691
52. Nsc 758691
53. Ncgc00095115-01
54. Ncgc00095115-02
55. Ncgc00095115-03
56. Acridin-9-amine;4-hexylbenzene-1,3-diol
57. Sbi-0052753.p002
58. D02759
59. Ab00053836_02
60. Sr-05000001975
61. Q4675133
62. Sr-05000001975-1
63. Brd-m49658242-001-02-5
64. Brd-m49658242-001-03-3
| Molecular Weight | 388.5 g/mol |
|---|---|
| Molecular Formula | C25H28N2O2 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 5 |
| Exact Mass | 388.215078140 g/mol |
| Monoisotopic Mass | 388.215078140 g/mol |
| Topological Polar Surface Area | 79.4 Ų |
| Heavy Atom Count | 29 |
| Formal Charge | 0 |
| Complexity | 354 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
ABOUT THIS PAGE
A Acrisorcin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Acrisorcin, including repackagers and relabelers. The FDA regulates Acrisorcin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Acrisorcin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Acrisorcin supplier is an individual or a company that provides Acrisorcin active pharmaceutical ingredient (API) or Acrisorcin finished formulations upon request. The Acrisorcin suppliers may include Acrisorcin API manufacturers, exporters, distributors and traders.
Acrisorcin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Acrisorcin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Acrisorcin GMP manufacturer or Acrisorcin GMP API supplier for your needs.
A Acrisorcin CoA (Certificate of Analysis) is a formal document that attests to Acrisorcin's compliance with Acrisorcin specifications and serves as a tool for batch-level quality control.
Acrisorcin CoA mostly includes findings from lab analyses of a specific batch. For each Acrisorcin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Acrisorcin may be tested according to a variety of international standards, such as European Pharmacopoeia (Acrisorcin EP), Acrisorcin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Acrisorcin USP).
LOOKING FOR A SUPPLIER?
